Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
BJUI Compass2024Vol. 5(11), pp. 1173–1182
Citations Over TimeTop 10% of 2024 papers
Liam Mannion, Verity Watson, Vinod Mullassery, Rajesh Nair, Thomas Charlton, Margaret Northover, Deborah Enting, Mieke Van Hemelrijck, Muhammad Shamim Khan, Ramesh Thurairaja, Suzanne Amery, Kathryn Chatterton, Kate Smith, Simon Hughes
Abstract
When deciding on the type of treatment, increased life expectancy is the most important consideration for people with MIBC. The risk of long-term complications and changes to overall body image as a result of treatment are also important. Our study also highlighted that patients are willing to accept a higher risk of long-term complications to improve other treatment outcomes. Understanding patient preferences is important for shared decision-making, which has an impact on quality of care for people living with MIBC.
Related Papers
- → Changes in life expectancy 1950–2010: contributions from age- and disease-specific mortality in selected countries(2016)105 cited
- → What happened to life expectancy in Spain in the 1980s?(1997)18 cited
- → THE ASSESSMENT OF PRIORITIES FOR INCREASING LIFE EXPECTANCY IN RUSSIA(2014)
- → Life expectancy and lifespan inequality: a perfect linear correlation? Analysis of the relationship with a particular emphasis on the case of countries going through the life expectancy stagnation period(2020)
- Healthy Life Expectancy and Health Gains in Cardiovascular Diseases Management in Korea(2012)